Soon after, British pharmacologists released the first CBD oil intended for therapeutic uses. Research into the potential health benefits of CBD continued to gain momentum around the world, catalysed by important research in the 1980s into CBD’s potential for supporting people with epilepsy.
By 2007, hemp cultivation licenses had been granted to two farmers in North Dakota, and in 2014, US President Barack Obama signed the ‘Farm Bill’, authorizing research institutes to start piloting hemp farming programs.
A later amendment to the Farm Bill in 2018 completely separated CBD and hemp from scheduled drugs banned by the Controlled Substances Act, which meant that hemp-derived CBD could not be treated as an illegal drug anymore.
The same year, the US Food and Drug Administration (FDA) approved the first CBD oral medication, Epidiolex, for the treatment of seizures in epilepsy patients aged 2 years and older.
Today, hemp-derived CBD is widely used as a dietary supplement, and consumers are able to choose from a variety of products, including CBD oils, CBD capsules, CBD topicals, CBD edibles and CBD vape juices.